当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析

君实生物-U

(688180)

  

流通市值:187.81亿  总市值:242.68亿
流通股本:7.63亿   总股本:9.86亿

君实生物-U(688180)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润-25.36亿元,每股收益-2.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益732061.05万元,未分配利润-906006.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产1134286.69万元,负债402225.64万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入1,502,549,915.75986,457,567.67669,702,667.07255,154,522.24
营业总成本3,811,859,509.42,479,371,840.851,772,814,913.95897,619,704.33
营业利润-2,457,442,353.76-1,580,362,717.66-1,162,291,985.5-633,218,295.88
利润总额-2,491,694,600.59-1,607,515,370.44-1,176,824,289.32-637,453,868.76
净利润-2,535,689,297.85-1,555,128,891.35-1,126,329,526.49-639,619,944.79
其他综合收益-73,658,461.53-50,732,766.43-38,178,177.32-27,447,285.04
综合收益总额-2,609,347,759.38-1,605,861,657.78-1,164,507,703.81-667,067,229.83
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计5,571,075,088.715,782,947,053.416,423,505,057.986,791,366,233.02
非流动资产合计5,771,791,782.625,804,197,167.985,355,971,828.975,339,562,243.28
资产总计11,342,866,871.3311,587,144,221.3911,779,476,886.9512,130,928,476.3
流动负债合计2,438,397,575.551,849,722,788.781,838,841,490.221,757,007,064.85
非流动负债合计1,583,858,823.81,399,722,758.661,155,125,700.21,099,543,899.25
负债合计4,022,256,399.353,249,445,547.442,993,967,190.422,856,550,964.1
归属于母公司股东权益合计7,151,224,186.478,064,611,883.598,493,075,006.928,949,235,488.32
股东权益合计7,320,610,471.988,337,698,673.958,785,509,696.539,274,377,512.2
负债和股东权益合计11,342,866,871.3311,587,144,221.3911,779,476,886.9512,130,928,476.3
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计1,741,533,154.581,236,480,347.79724,254,775.41302,002,091.08
经营活动现金流出小计3,746,515,251.552,900,594,540.441,949,976,576.481,022,253,055.97
经营活动产生的现金流量净额-2,004,982,096.97-1,664,114,192.65-1,225,721,801.07-720,250,964.89
投资活动现金流入小计1,358,391,615.61,290,836,234.041,265,278,847432,767,530.31
投资活动现金流出小计2,291,582,521.721,944,670,480.181,431,430,071.66925,640,355.94
投资活动产生的现金流量净额-933,190,906.12-653,834,246.14-166,151,224.66-492,872,825.63
筹资活动现金流入小计1,340,578,673.91937,789,838.5411,620,629.53248,567,750.19
筹资活动现金流出小计628,750,893.95496,595,535.82188,022,407.3737,114,589.49
筹资活动产生的现金流量净额711,827,779.96441,194,302.68223,598,222.16211,453,160.7
汇率变动对现金及现金等价物的影响7,551,261.1821,536,381.0525,100,592.95-10,637,565.29
现金及现金等价物净增加额-2,218,793,961.95-1,855,217,755.06-1,143,174,210.62-1,012,308,195.11
期末现金及现金等价物余额3,778,142,035.884,141,718,242.774,853,761,787.214,984,627,802.72
最新报告期:2024-04-08
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
方正证券周超泽-1.870.040.822024-04-08
广发证券李安飞,罗佳荣-1.50-0.84-0.112024-04-06
方正证券周超泽-1.870.040.822024-03-29
中信证券陈竹-2.28-1.50-0.172024-02-28
中信证券陈竹,韩世通-1.50-0.17--2024-02-28
TOP↑